Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 98496

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 26, 2026
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
New Life Pharma LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.

D-0392-2026
Recall number
D-0392-2026
Initiated
February 26, 2026
Classification
Class II
Status
Ongoing
Recalling firm
New Life Pharma LLC
Quantity
820 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

Lot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027

Distribution pattern

OH

drug · product 2 of 4

Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06

D-0393-2026
Recall number
D-0393-2026
Initiated
February 26, 2026
Classification
Class II
Status
Ongoing
Recalling firm
New Life Pharma LLC
Quantity
2 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

Lot 240903, exp 9/30/2026

Distribution pattern

OH

drug · product 3 of 4

Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.

D-0394-2026
Recall number
D-0394-2026
Initiated
February 26, 2026
Classification
Class II
Status
Ongoing
Recalling firm
New Life Pharma LLC
Quantity
23 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

Lot 240709, exp 7/31/2026

Distribution pattern

OH

drug · product 4 of 4

Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.

D-0395-2026
Recall number
D-0395-2026
Initiated
February 26, 2026
Classification
Class II
Status
Ongoing
Recalling firm
New Life Pharma LLC
Quantity
45 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

Lot 240709, exp 7/31/2026

Distribution pattern

OH